{"data":[{"accessionNo":"0001104659-26-096939","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":10234862,"percentOfClass":9.95,"filedAt":"2026-08-14"},{"accessionNo":"0001104659-26-096939","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":10234862,"percentOfClass":9.95,"filedAt":"2026-08-14"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Management, L.L.C.","reportingCik":null,"personType":"IA,OO","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"HC,IN","sharesOwned":10282210,"percentOfClass":9.99,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Healthcare Partners Master, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Healthcare Partners (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0000908834-26-000397","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13"},{"accessionNo":"0002100119-26-000189","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":5122475,"percentOfClass":5.02,"filedAt":"2026-04-29"},{"accessionNo":"0000102909-26-000785","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc","ticker":"BEAM","cusip":"07373V105","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0000093751-26-000023","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001745999","issuerName":"BEAM THERAPEUTICS INC","ticker":"BEAM","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":5228529,"percentOfClass":5.2,"filedAt":"2026-02-09"},{"accessionNo":"0000315066-26-000356","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001745999","issuerName":"BEAM THERAPEUTICS INC","ticker":"BEAM","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":12750369.42,"percentOfClass":12.6,"filedAt":"2026-02-05"},{"accessionNo":"0000315066-26-000356","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001745999","issuerName":"BEAM THERAPEUTICS INC","ticker":"BEAM","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":12750369.42,"percentOfClass":12.6,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"IN","sharesOwned":10141856,"percentOfClass":9.99,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":9808603,"percentOfClass":9.7,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Healthcare Partners Master, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6068735,"percentOfClass":6,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Healthcare Partners (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":6068735,"percentOfClass":6,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1632718,"percentOfClass":1.6,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":836691,"percentOfClass":0.8,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":688623,"percentOfClass":0.7,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":333253,"percentOfClass":0.3,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":333253,"percentOfClass":0.3,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":233233,"percentOfClass":0.2,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":150101,"percentOfClass":0.1,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":104266,"percentOfClass":0.1,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":150101,"percentOfClass":0.1,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":94237,"percentOfClass":0.1,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Fried, Richard B","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Seybold, William","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-05"},{"accessionNo":"0000908834-26-000048","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock, par value $0.01 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Patel, Rajiv A.","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-05"},{"accessionNo":"0001104659-26-009583","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":12467189,"percentOfClass":12.29,"filedAt":"2026-02-03"},{"accessionNo":"0001104659-26-009583","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001745999","issuerName":"Beam Therapeutics Inc.","ticker":"BEAM","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":12467189,"percentOfClass":12.29,"filedAt":"2026-02-03"},{"accessionNo":"0000315066-25-002693","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001745999","issuerName":"BEAM THERAPEUTICS INC","ticker":"BEAM","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":13766517.7,"percentOfClass":13.6,"filedAt":"2025-11-05"},{"accessionNo":"0000315066-25-002693","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001745999","issuerName":"BEAM THERAPEUTICS INC","ticker":"BEAM","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":13766517.7,"percentOfClass":13.6,"filedAt":"2025-11-05"}],"updatedAt":"2026-10-13T01:13:20.573Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}